115 related articles for article (PubMed ID: 10402239)
21. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model.
Sormunen RT; Leong AS; Vääräniemi JP; Fernando SS; Eskelinen SM
J Pathol; 1999 Mar; 187(4):416-23. PubMed ID: 10398100
[TBL] [Abstract][Full Text] [Related]
22. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast.
Gillett CE; Miles DW; Ryder K; Skilton D; Liebman RD; Springall RJ; Barnes DM; Hanby AM
J Pathol; 2001 Apr; 193(4):433-41. PubMed ID: 11276001
[TBL] [Abstract][Full Text] [Related]
23. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
Ashida K; Terada T; Kitamura Y; Kaibara N
Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
[TBL] [Abstract][Full Text] [Related]
24. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
Nakanishi Y; Ochiai A; Akimoto S; Kato H; Watanabe H; Tachimori Y; Yamamoto S; Hirohashi S
Oncology; 1997; 54(2):158-65. PubMed ID: 9075789
[TBL] [Abstract][Full Text] [Related]
25. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
26. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
27. [Expression of cell adhesion molecules E-cadherin and beta-catenin in infiltrating breast carcinoma].
Chipysheva TA; Gel'shteĭn VI; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
Arkh Patol; 2003; 65(3):3-7. PubMed ID: 12879601
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
29. Usefulness and limitations of E-cadherin and β-catenin in the classification of breast carcinomas in situ with mixed pattern.
Gomes DS; Porto SS; Rocha RM; Gobbi H
Diagn Pathol; 2013 Jul; 8():114. PubMed ID: 23837653
[TBL] [Abstract][Full Text] [Related]
30. Immunoexpression of E-cadherin and beta-catenin correlates to survival of patients with hepatocellular carcinomas.
Garcia S; Martini F; De Micco C; Andrac L; Hardwigsen J; Sappa P; Lavaut MN; Le Treut YP; Charpin C
Int J Oncol; 1998 Feb; 12(2):443-7. PubMed ID: 9458373
[TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer.
Nurismah MI; Noriah O; Suryati MY; Sharifah NA
Asian Pac J Cancer Prev; 2008; 9(4):699-702. PubMed ID: 19256762
[TBL] [Abstract][Full Text] [Related]
33. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.
Siitonen SM; Kononen JT; Helin HJ; Rantala IS; Holli KA; Isola JJ
Am J Clin Pathol; 1996 Apr; 105(4):394-402. PubMed ID: 8604681
[TBL] [Abstract][Full Text] [Related]
34. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of p53 protein expression in breast carcinomas.
Hurlimann J
Pathol Res Pract; 1993 Nov; 189(9):996-1003. PubMed ID: 8302733
[TBL] [Abstract][Full Text] [Related]
36. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas.
Bánkfalvi A; Krassort M; Végh A; Felszeghy E; Piffkó J
J Oral Pathol Med; 2002 Sep; 31(8):450-7. PubMed ID: 12220351
[TBL] [Abstract][Full Text] [Related]
37. Beta- and gamma-catenin expression in thyroid carcinomas.
Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous bilateral breast carcinoma: Histopathological characteristics and CD44/catenin-cadherin profile.
Bassarova AV; Torlakovic E; Sedloev T; Hristova SL; Trifonov DV; Nesland JM
Histol Histopathol; 2005 Jul; 20(3):791-9. PubMed ID: 15944928
[TBL] [Abstract][Full Text] [Related]
39. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
[TBL] [Abstract][Full Text] [Related]
40. The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast.
Tan DS; Potts HW; Leong AC; Gillett CE; Skilton D; Harris WH; Liebmann RD; Hanby AM
J Pathol; 1999 Sep; 189(1):20-7. PubMed ID: 10451483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
